PRTODAY / NewswireToday Free press release distribution service network

More news: Research
Agency / Source: Frost & Sullivan

This article was published free of charge. Only PREMIUM Articles are (Google AdSense™) 3rd party Ads-Free!

Rampant Adoption of qRT-PCR and Next Generation DNA Sequencing Technologies Expected to Drive the U.S. Genomics Markets - New analysis from Frost & Sullivan, Strategic Analysis of U.S. Genomics Markets, reveals that revenues in this market totaled $1.85 billion in 2006, and is likely to reach $3.69 billion in 2012
Rampant Adoption of qRT-PCR and Next Generation DNA Sequencing Technologies Expected to Drive the U.S. Genomics Markets

 

NewswireToday - /newswire/ - Palo Alto, CA, United States, 08/20/2007 - New analysis from Frost & Sullivan, Strategic Analysis of U.S. Genomics Markets, reveals that revenues in this market totaled $1.85 billion in 2006, and is likely to reach $3.69 billion in 2012.

   
 


Rank or share this free Newswire Press Release Distribution content. Join the network! Learn How!


Your Banner Ad Here instead - Showing along with ALL Articles covering Research Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour.


 

While the days of high market growth, driven by the human genome project, are behind us, the era of personal genomics is yet to begin. Next generation genomics technologies are breathing new life into the market, and are expected to contribute to the robust growth of the U.S. genomics market between 2005 and 2012. Top industry participants are successfully developing specific applications for each evolutionary stage of the genomics research process, and are likely to maintain revenue streams, while strategically positioning themselves to penetrate the future markets for clinical applications of genomic technologies.

New analysis from Frost & Sullivan (drugdiscovery.frost.com), Strategic Analysis of U.S. Genomics Markets, reveals that revenues in this market totaled $1.85 billion in 2006, and is likely to reach $3.69 billion in 2012.

If you are interested in a virtual brochure, which provides manufacturers, end users, and other industry participants an overview of the latest analysis of the Strategic Analysis of U.S. Genomics Markets, then send an email to Melina Trevino - Corporate Communications at melina.trevino[.]frost.com with the following information: your full name, company name, title, telephone number, email address, city, state, and country. We will send you the information via email upon receipt of the above information.

“Among the market segments, quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) technology, including instrumentation and reagents, is developing as the fastest growing segment of the total U.S. genomics market,” notes Frost & Sullivan Industry Analyst Jonathan Witonsky. “As researchers attempt to validate discoveries made on the foundation of The Human Genome Project, they find technologies such as qRT-PCR ideal for their targeted studies.”

Following the qRT-PCR segment, DNA microarray technology is developing as the second-fastest growing segment of the total U.S. genomics market. While genome-wide expression analyses are forecasted to drive the majority of DNA microarray segment growth, markets related to novel genomics analyses, such as comparative genomic hybridization (CGH), genome-wide methylation studies, and chromatin immunoprecipitation (ChIP)-chip, are likely to see the highest growth. Finally, the majority of the DNA sequencing technology segment growth is anticipated to result from the introduction and extensive placement of next generation DNA sequencing technologies.

Despite these positives, genomics platforms that are too inefficient and expensive for ultra-high throughput comprehensive genome-wide analysis are hindering the realization of personal genomics. Moreover, the markets for last-generation genomics technologies, such as general polymerase chain reaction (PCR) and conventional DNA sequencing, are beginning to stabilize.

“Conventional genomics technologies require a considerable amount of time to operate and cost too much per analysis for the types of genomics studies that are expected to ultimately transform biomedical research, and, subsequently, molecular diagnostics, pharmacogenomics, drug discovery and development, and personalized medicine,” says Witonsky. “The lack of efficiency and cost-effectiveness of conventional genomics technologies prevent full fledged utilization that could drive revenue growth.”

While numerous initiatives continue to support the application of multiple genomics technologies, market participants must strategically position their genomics technologies with applications that enable customers to make a smooth research transition from discovery to validation.

Strategic Analysis of U.S. Genomics Markets is part of the Drug Discovery Technologies Subscription, which also includes research in the following markets: U.S. sequencing services markets, U.S. DNA microarray markets, U.S. microfluidics/lab-on-a-chip markets, U.S. nucleic acid isolation markets and U.S. RNAi markets. All research services included in subscriptions provide detailed market opportunities and industry trends evaluated following extensive interviews with market participants. Interviews are available to the press.

About Frost & Sullivan

Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company's industry expertise integrates growth consulting, growth partnership services, and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community by providing comprehensive industry coverage that reflects a unique global perspective, and combines ongoing analysis of markets, technologies, econometrics, and demographics.

 
 


Rank or share this free Newswire Press Release Distribution content. Join the network! Learn How!


Your Banner Ad Here instead - Showing along with ALL Articles covering Research Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour.


 

Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Research articles,
CATCH Visitors via Your Competitors Announcements!


Rampant Adoption of qRT-PCR and Next Generation DNA Sequencing Technologies Expected to Drive the U.S. Genomics Markets

Non-featured company website links are shown on a random basis
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  For more information, please visit:
Links are available on a random basis for non premium members
|
Contact: Melina Trevino 
210.247.2440 melina.trevino[.]frost.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Research via RSS
AddThis press release: Rampant Adoption of qRT-PCR and Next Generation DNA Sequencing Technologies Expected to Drive the U.S. Genomics MarketsAdd Research News to My MSNAdd Research News to My Yahoo!Add NewswireToday Research Press Release Headline News to Your Google homepage or Google ReaderAdd NewswireToday - PRZOOM Headline News to FeedBurner Twitter /NewswireToday

This article was published free of charge. Only PREMIUM Articles are (Google AdSense™) 3rd party Ads-Free!


Read Latest Articles From Frost & Sullivan / Company Profile



Smartphone Concepts and Apps to Create New Revenue Streams for European Vehicle Manufacturers Finds Frost & Sullivan
Growth in 3G and 4G Enhances Prospects for the World Triple Play and Next Generation Services Test and Monitoring Equipment Market
Armed Forces Modernization and Defense Offsets to Create Opportunities for IT in India's Defense Market Fidns Frost & Sullivan
European Thrombosis Therapeutics Market is Experiencing an Urgent Need for Enhanced Products Says Frost & Sullivan
MIRTEC Superbly Leverages Customer Service Strategies to Cement its Brand Image and Enhance Customer Loyalty in the SMT Equipment Market
Improving Government Regulations to Lift Entry Barriers in Next Generation Network Market in Europe Finds Frost & Sullivan
Investments in Italian Civil Security Market Set to Exceed €1.60 billion Over 2011-2015 Projects Frost & Sullivan
Rising Interest of Big Pharma Creates Immense Growth Potential for Contract Manufacturing Organisations Says Frost & Sullivan
High-end, High-performance Systems to Energise European Signal Generator and Arbitrary Waveform Generator Market Says Frost & Sullivan
Rapidly Evolving Stem Cells Market Opens Up Doors for Related Research Tools Says Frost & Sullivan
Global Flow Sensors and Transmitters Market – Recovery of End-user Industries will Accelerate Growth Finds Frost & Sullivan
Frost & Sullivan Acclaims NETZSCH's Customer-Centric Business Goals that Resulted in Innovative Products and Solutions
Frost & Sullivan Publishes Strategic Analysis of the North American Class 6-8 Natural Gas Truck Market
Frost & Sullivan Honor Underlines Courtagen Life Sciences’ Commitment to Innovation which Facilitates Breakthroughs in Biomedical Research
Frost & Sullivan Recognizes DigitalRoute for its Billing Mediation Solution and Go-to-Market Partner Strategy

Reserve This Permanent SPACE

Your LOGO permanently HERE on Newswire Today most visited Page start at $295 per month

 
Sponsored Links


Visit  Pickerel Lake Recovery Treatment Center

Visit  Write It Well (WiW)










 
  ©2012 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise | Contact | Investors | Sitemap | FRANCAIS
newswire, PR free press releases distribution magazines engine news alert newsroom press room breaking news public relations articles company news alerts blogsIt younews.me newswiredistribution ezine younews.asia bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri- bution today investor relation successful internet entrepreneur free newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)